ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Kinnate Biopharma Inc Delisted | KNTE | United States of America | — | 246 |
| Transition Therapeutics Inc (USA) Delisted | TTHI | United States of America | — | 245 |
| Large Scale Biology Corp Delisted | LSBC | United States of America | — | 243 |
| ARYx Therapeutics, Inc. Delisted | — | United States of America | — | 242 |
| ADVANCED VIRAL RESEARCH CORP Delisted | — | United States of America | — | 241 |
| Cordex Pharma, Inc. Delisted | — | United States of America | — | 240 |
| Cougar Biotechnology, Inc. Delisted | — | United States of America | — | 240 |
| Kuvatris Therapeutics, Inc. Delisted | — | United States of America | — | 239 |
| TheraVet SA | ALVET | Belgium | — | 239 |
| Original BioMedicals Co., Ltd. | 6483 | Taiwan | — | 236 |
| Comera Life Sciences Holdings Inc Delisted | CMRAW | United States of America | — | 235 |
| PROTEIN POLYMER TECHNOLOGIES INC Delisted | — | United States of America | — | 234 |
| Redpoint Bio CORP Delisted | — | United States of America | — | 234 |
| CHA Vaccine Research Institute | 261780 | South Korea | — | 231 |
| EQRx Inc Delisted | EQRX | United States of America | — | 231 |
| HEMOBIOTECH, INC. Delisted | — | United States of America | — | 231 |
| Codiak BioSciences Inc Delisted | CDAK | United States of America | — | 230 |
| Principia Biopharma Inc Delisted | PRNB | United States of America | — | 229 |
| TETRALOGIC PHARMACEUTICALS Corp Delisted | — | United States of America | — | 228 |
| Third Harmonic Bio Inc. Delisted | THRD | United States of America | — | 228 |
| TME Pharma N.V. | ALTME | Netherlands | — | 228 |
| CHEMOKINE THERAPEUTICS CORP Delisted | — | United States of America | — | 227 |
| Nascent Biotech Inc. Delisted | — | United States of America | — | 227 |
| SGX PHARMACEUTICALS, INC. Delisted | — | United States of America | — | 227 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 1541 | Hong Kong | — | 224 |
| Lir Life Sciences Corp. | SKNY | Canada | — | 224 |
| Omega Therapeutics Inc Delisted | OMGA | United States of America | — | 224 |
| Telesta Therapeutics Inc. Delisted | TST | Canada | — | 224 |
| ACELYRIN, Inc. Delisted | — | United States of America | — | 223 |
| Cotinga Pharmaceuticals Inc. Delisted | COT | Canada | — | 222 |
| Oncorus Inc Delisted | ONCR | United States of America | — | 222 |
| Qyuns Therapeutics Co., Ltd. | 2509 | Hong Kong | — | 222 |
| ABBOTT BIOTHERAPEUTICS CORP Delisted | — | United States of America | — | 221 |
| Infant Bacterial Therapeutics | IBT | Sweden | — | 221 |
| Sqz Biotechnologies Co Delisted | SQZ | United States of America | — | 221 |
| TRIANGLE PHARMACEUTICALS INC Delisted | — | United States of America | — | 221 |
| Hillevax Inc Delisted | HLVX | United States of America | — | 220 |
| Rich Pharmaceuticals, Inc. Delisted | — | United States of America | — | 220 |
| Thiogenesis Therapeutics, Corp. | TTI | Canada | — | 220 |
| Cyteir Therapeutics Inc Delisted | CYT | United States of America | — | 219 |
| Minerco, Inc. Delisted | — | United States of America | — | 219 |
| Moogene Medi Co., Ltd. | 322970 | South Korea | — | 219 |
| Shaperon Inc. | 378800 | South Korea | — | 219 |
| Great Novel Therapeutics Biotech & Medicals | 7427 | Taiwan | — | 217 |
| Holy Stone Healthcare Co., Ltd. | 4194 | Taiwan | — | 217 |
| NexImmune, Inc. Delisted | — | United States of America | — | 217 |
| Eidos Therapeutics Inc Delisted | EIDX | United States of America | — | 216 |
| IRLAB Therapeutics | IRLAB | Sweden | — | 216 |
| Chordia Therapeutics,Inc | 190A | Japan | — | 215 |
| D&D Pharmatech Inc. | 347850 | South Korea | — | 215 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.